This is an international site for AFINITOR® (everolimus) and is intended for Health Care Professionals outside the U.S. The information on the site is not country-specific, and may contain information that is outside the approved indications in the country in which you are located. Please contact your local Novartis representative for the latest information specific to your country

I am a healthcare professional outside of the US I am a US Resident I am a patient outside of the US

AFINITOR® (everolimus) Logo | AFINITOR.com
AFINITOR is a once-daily oral inhibitor of mTOR (mammalian target of rapamycin) for patients with advanced renal cell carcinoma (RCC) whose disease has progressed on or after treatment with VEGF-targeted therapy
Afinitor now approved in the EU!
Afinitor International Website  |  For Healthcare Professionals Outside the U.S.  |  US Residents
Dosing & Administration

AFINITOR For Your Patients

Stay informed on the latest information, including news related to AFINITOR and other updates.

Register for Afinitor Updates
Afinitor Approved Countries

Patient Support Tools

AFINITOR® (everolimus) tools to support your patients with advanced renal cell carcinoma after disease progression on or after sunitinib or sorafenib as they transition to AFINITOR therapy

Patient education and communication are the keys to effective treatment. Novartis remains dedicated to helping your practice by providing valuable and easy-to-use patient education and support materials. Many of the materials below can be downloaded for your patients with advanced renal cell carcinoma.

Understanding Renal Cell Carcinoma Brochure (Coming Soon)
Information to help your patients better understand and manage their disease.

AFINITOR Starter Brochure (Coming Soon)
Easy-to-understand information for patients that reinforces your instructions by explaining what AFINITOR is, what you should know before taking AFINITOR, how to take AFINITOR and common side effects.

AFINITOR Treatment Journey Brochure (Coming Soon)
Comprehensive treatment planning tool filled with resources to help patients get the most out of their AFINITOR therapy.